169 related articles for article (PubMed ID: 31431500)
1. Bufalin, a Traditional Chinese Medicine Compound, Prevents Tumor Formation in Two Murine Models of Colorectal Cancer.
Sun X; Ng TTH; Sham KWY; Zhang L; Chan MTV; Wu WKK; Cheng CHK
Cancer Prev Res (Phila); 2019 Oct; 12(10):653-666. PubMed ID: 31431500
[TBL] [Abstract][Full Text] [Related]
2. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
3. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice].
Gu W; Han KQ; Su YH; Huang XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2007 Mar; 5(2):155-9. PubMed ID: 17352871
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
6. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.
Li M; Yu X; Guo H; Sun L; Wang A; Liu Q; Wang X; Li J
Tumour Biol; 2014 Mar; 35(3):2461-71. PubMed ID: 24218335
[TBL] [Abstract][Full Text] [Related]
7. Novel augmentation by bufalin of protein kinase C-induced cyclooxygenase-2 and IL-8 production in human breast cancer cells.
Chen HT; Sun D; Peng YC; Kao PH; Wu YL
Innate Immun; 2017 Jan; 23(1):54-66. PubMed ID: 27821648
[TBL] [Abstract][Full Text] [Related]
8. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
[TBL] [Abstract][Full Text] [Related]
9. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.
Xie CM; Chan WY; Yu S; Zhao J; Cheng CH
Free Radic Biol Med; 2011 Oct; 51(7):1365-75. PubMed ID: 21763418
[TBL] [Abstract][Full Text] [Related]
10. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.
Li D; Qu X; Hou K; Zhang Y; Dong Q; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Jan; 20(1):59-64. PubMed ID: 19343001
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
Qiu YY; Hu Q; Tang QF; Feng W; Hu SJ; Liang B; Peng W; Yin PH
Tumour Biol; 2014 Mar; 35(3):2599-606. PubMed ID: 24375248
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of low-dose aloe-emodin on the development of colorectal tumors in min mice.
Shimpo K; Chihara T; Kaneko T; Beppu H; Wakamatsu K; Shinzato M; Yukitake J; Sonoda S
Asian Pac J Cancer Prev; 2014; 15(14):5587-92. PubMed ID: 25081669
[TBL] [Abstract][Full Text] [Related]
13. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
14. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.
Zou D; Song J; Deng M; Ma Y; Yang C; Liu J; Wang S; Wen Z; Tang Y; Qu X; Zhang Y
FASEB J; 2021 May; 35(5):e21601. PubMed ID: 33913201
[TBL] [Abstract][Full Text] [Related]
15. Bufalin induces cell cycle arrest and apoptosis in gallbladder carcinoma cells.
Jiang L; Zhao MN; Liu TY; Wu XS; Weng H; Ding Q; Shu YJ; Bao RF; Li ML; Mu JS; Wu WG; Ding QC; Cao Y; Hu YP; Shen BY; Tan ZJ; Liu YB
Tumour Biol; 2014 Nov; 35(11):10931-41. PubMed ID: 25085580
[TBL] [Abstract][Full Text] [Related]
16. Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells.
Li A; Qu X; Li Z; Qu J; Song N; Ma Y; Liu Y
Mol Med Rep; 2015 Aug; 12(2):2926-32. PubMed ID: 25936899
[TBL] [Abstract][Full Text] [Related]
17. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.
Wu SH; Bau DT; Hsiao YT; Lu KW; Hsia TC; Lien JC; Ko YC; Hsu WH; Yang ST; Huang YP; Chung JG
Environ Toxicol; 2017 Apr; 32(4):1305-1317. PubMed ID: 27444971
[TBL] [Abstract][Full Text] [Related]
18. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
19. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
Xiang RF; Wang Y; Zhang N; Xu WB; Cao Y; Tong J; Li JM; Wu YL; Yan H
Cell Death Dis; 2017 May; 8(5):e2776. PubMed ID: 28492559
[TBL] [Abstract][Full Text] [Related]
20. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
Zhan Y; Qiu Y; Wang H; Wang Z; Xu J; Fan G; Xu J; Li W; Cao Y; Le VM; Ly HT; Yuan Z; Xu K; Yin P
Cancer Sci; 2020 May; 111(5):1619-1630. PubMed ID: 32058643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
